<DOC>
	<DOC>NCT02079480</DOC>
	<brief_summary>The purpose of this study is to evaluate the safety and tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of BMS-986090 in healthy subjects.</brief_summary>
	<brief_title>Study to Evaluate the Safety, Tolerability, PK, and PD of BMS-986090 in Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Keyhole-limpet hemocyanin</mesh_term>
	<criteria>For more information regarding BMS clinical trial participation, please visit www.BMSStudyConnect.com. Healthy male and female (of not childbearing potential), ages 1845 years, inclusive BMI 18 to 32 kg/m2, inclusive Any significant acute or chronic medical illness</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>